相似文献
1
Opioid-induced preconditioning is dependent on caveolin-3 expression.
Anesth Analg. 2010 Nov;111(5):1117-21. doi: 10.1213/ANE.0b013e3181f3351a. Epub 2010 Aug 24.
2
Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.
Arterioscler Thromb Vasc Biol. 2012 Apr;32(4):934-42. doi: 10.1161/ATVBAHA.111.242164. Epub 2012 Feb 9.
3
Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.
Am J Physiol Heart Circ Physiol. 2014 Sep 15;307(6):H895-903. doi: 10.1152/ajpheart.00081.2014. Epub 2014 Jul 25.
4
Acute methadone treatment reduces myocardial infarct size via the delta-opioid receptor in rats during reperfusion.
Anesth Analg. 2009 Nov;109(5):1395-402. doi: 10.1213/ANE.0b013e3181b92201.
5
Intrathecal morphine preconditioning induces cardioprotection via activation of delta, kappa, and mu opioid receptors in rats.
Anesth Analg. 2009 Jan;108(1):23-9. doi: 10.1213/ane.0b013e3181884ba6.
6
Mechanistic insights into δ-opioid-induced cardioprotection: Involvement of caveolin translocation to the mitochondria.
Life Sci. 2020 Apr 15;247:116942. doi: 10.1016/j.lfs.2019.116942. Epub 2019 Nov 9.
7
Activation of Peripheral Opioid Kappa1 Receptor Prevents Cardiac Reperfusion Injury.
Physiol Res. 2021 Aug 31;70(4):523-531. doi: 10.33549/physiolres.934646. Epub 2021 Jun 1.
8
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.
Circulation. 2008 Nov 4;118(19):1979-88. doi: 10.1161/CIRCULATIONAHA.108.788331. Epub 2008 Oct 20.
9
Remifentanil post-conditioning attenuates cardiac ischemia-reperfusion injury via kappa or delta opioid receptor activation.
Acta Anaesthesiol Scand. 2010 Apr;54(4):510-8. doi: 10.1111/j.1399-6576.2009.02145.x. Epub 2009 Oct 29.
10
Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.
Anesthesiology. 2010 May;112(5):1136-45. doi: 10.1097/ALN.0b013e3181d3d624.
引用本文的文献
1
Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury.
Mol Med. 2025 Feb 26;31(1):80. doi: 10.1186/s10020-025-01117-5.
2
Nitrative Modification of Caveolin-3: A Novel Mechanism of Cardiac Insulin Resistance and a Potential Therapeutic Target Against Ischemic Heart Failure in Prediabetic Animals.
Circulation. 2023 Apr 11;147(15):1162-1179. doi: 10.1161/CIRCULATIONAHA.122.063073. Epub 2023 Mar 8.
3
Leucine imparts cardioprotective effects by enhancing mTOR activity and mitochondrial fusion in a myocardial ischemia/reperfusion injury murine model.
Diabetol Metab Syndr. 2021 Nov 20;13(1):139. doi: 10.1186/s13098-021-00755-z.
4
[Significance of exosomes in cardiology: heralds of cardioprotection].
Arch Cardiol Mex. 2021;91(1):105-113. doi: 10.24875/ACM.20000335.
5
Hyperglycemia-Induced Oxidative Stress Abrogates Remifentanil Preconditioning-Mediated Cardioprotection in Diabetic Rats by Impairing Caveolin-3-Modulated PI3K/Akt and JAK2/STAT3 Signaling.
Oxid Med Cell Longev. 2019 Sep 5;2019:9836302. doi: 10.1155/2019/9836302. eCollection 2019.
6
Delta Opioids: Neuroprotective Roles in Preclinical Studies.
J Ocul Pharmacol Ther. 2018 Jan/Feb;34(1-2):119-128. doi: 10.1089/jop.2017.0039.
7
Caveolins as Regulators of Stress Adaptation.
Mol Pharmacol. 2018 Apr;93(4):277-285. doi: 10.1124/mol.117.111237. Epub 2018 Jan 22.
8
Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion.
Am J Physiol Cell Physiol. 2016 Dec 1;311(6):C854-C865. doi: 10.1152/ajpcell.00147.2016. Epub 2016 Oct 5.
9
Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.
Br J Pharmacol. 2016 Oct;173(20):2966-91. doi: 10.1111/bph.13552. Epub 2016 Sep 9.
10
Molecular Pharmacology of δ-Opioid Receptors.
Pharmacol Rev. 2016 Jul;68(3):631-700. doi: 10.1124/pr.114.008979.
本文引用的文献
1
Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.
Anesthesiology. 2010 May;112(5):1136-45. doi: 10.1097/ALN.0b013e3181d3d624.
2
Anaesthesia and myocardial ischaemia/reperfusion injury.
Br J Anaesth. 2009 Jul;103(1):89-98. doi: 10.1093/bja/aep141. Epub 2009 Jun 5.
3
Clinical cardioprotection and the value of conditioning responses.
Am J Physiol Heart Circ Physiol. 2009 Jun;296(6):H1705-20. doi: 10.1152/ajpheart.00162.2009. Epub 2009 Apr 10.
4
Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.
Circulation. 2008 Nov 4;118(19):1979-88. doi: 10.1161/CIRCULATIONAHA.108.788331. Epub 2008 Oct 20.
5
Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.
J Mol Cell Cardiol. 2008 Jan;44(1):123-30. doi: 10.1016/j.yjmcc.2007.10.003. Epub 2007 Oct 11.
6
Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization.
Life Sci. 2007 Sep 22;81(15):1223-7. doi: 10.1016/j.lfs.2007.08.031. Epub 2007 Sep 9.
7
Caveolae as organizers of pharmacologically relevant signal transduction molecules.
Annu Rev Pharmacol Toxicol. 2008;48:359-91. doi: 10.1146/annurev.pharmtox.48.121506.124841.
8
Mechanisms of cardiac protection from ischemia/reperfusion injury: a role for caveolae and caveolin-1.
FASEB J. 2007 May;21(7):1565-74. doi: 10.1096/fj.06-7719com. Epub 2007 Feb 1.
9
The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
Arch Mal Coeur Vaiss. 2006 Mar;99(3):242-6.
10
Protection of adult rat cardiac myocytes from ischemic cell death: role of caveolar microdomains and delta-opioid receptors.
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H344-50. doi: 10.1152/ajpheart.01100.2005. Epub 2006 Feb 24.
Zotero 插件